BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/21/2020 6:42:51 AM | Browse: 783 | Download: 1998
 |
Received |
|
2020-05-05 09:36 |
 |
Peer-Review Started |
|
2020-05-05 09:37 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2020-05-15 18:24 |
 |
Revised |
|
2020-05-22 03:50 |
 |
Second Decision |
|
2020-07-29 06:58 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2020-07-30 05:33 |
 |
Articles in Press |
|
2020-07-30 05:33 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2020-08-03 02:45 |
 |
Typeset the Manuscript |
|
2020-08-17 00:36 |
 |
Publish the Manuscript Online |
|
2020-08-21 06:42 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Radiology, Nuclear Medicine & Medical Imaging |
Manuscript Type |
Retrospective Study |
Article Title |
Prognostic value of pretreatment contrast-enhanced computed tomography in esophageal neuroendocrine carcinoma: A multi-center follow-up study
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Yue Zhou, Ping Hou, Kai-Ji Zha, Feng Wang, Kun Zhou, Wei He and Jian-Bo Gao |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China (General Program) |
81671682 |
Medical Science and Technology Project of Henan Province |
201602012 |
|
Corresponding Author |
Jian-Bo Gao, MD, PhD, Professor, Department of Radiology, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe Road, Zhengzhou 450052, Henan Province, China. cjr_gaojianbo@163.com |
Key Words |
Esophageal neuroendocrine carcinoma; Computed tomography; Prognosis; Survival; Follow-up; Adjuvant chemotherapy |
Core Tip |
The occurrence of esophageal neuroendocrine carcinoma (NEC) is rare. The clinical data included in the previous prognostic models were limited and imaging data were lacking. Our results demonstrate that adjuvant chemotherapy is an independent prognostic factor of overall survival and progression-free survival. In addition, the N stage and degree of enhancement were prognostic factors of overall survival for patients with esophageal NEC. Furthermore, adjuvant chemotherapy was significantly associated with degree of enhancement, while degree of enhancement significantly correlated with esophageal wall thickness. |
Publish Date |
2020-08-21 06:42 |
Citation |
Zhou Y, Hou P, Zha KJ, Wang F, Zhou K, He W, Gao JB. Prognostic value of pretreatment contrast-enhanced computed tomography in esophageal neuroendocrine carcinoma: A multi-center follow-up study. World J Gastroenterol 2020; 26(31): 4680-4693 |
URL |
https://www.wjgnet.com/1007-9327/full/v26/i31/4680.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v26.i31.4680 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345